LindqvistO, LundquistG, DickmanA, BükkiJ, LunderU, HagelinCLet al.Four essential drugs needed for quality care of the dying: A Delphi-study based international expert consensus opinion. J Palliat Med, 2013; 16,1:38–43.
2.
DonaldsonMS, FieldMJ. Measuring quality of care at the end of life. Arch Intern Med, 1998; 158,2:121–128.
3.
SteinhauserKE, ChristakisNA, ClippEC, McNeillyM, McIntyreL, TulskyJA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA, 2000; 284,19:2476–2482.
4.
StefanouN, FairclothS. Exploring the concept of quality care for the person who is dying. Br J Community Nurs, 2010; 15,12:588–593.
5.
LikarR. Klinische Untersuchung ûber dieWirkung von Scopolamin-Hydrobromicum beim terminalen Rasseln (randomisierte, doppelblind, plazebokontrollierte studie) [Study about the efficacy of scopolamin-hydrobromicum in terminal rattle (randomized, double-blind, placebo-controlled study)Z Palliativmed, 2002; 3,15e:19.
6.
RowettD, RavenscroftPJ, HardyJ, CurrowDC. Using national health policies to improve access to palliative care medications in the community. J Pain Symptom Manage, 2009; 37,3:395–402.
